BTIG’s Life Science and Diagnostic Tools Analyst Karen Koski Named an All-America Research Team Rising Star by Institutional Investor Magazine

New York – November 7, 2016 – BTIG, LLC announced today that Karen Koski, Director and BTIG’s Life Science and Diagnostic Tools Analyst, was named an All-America Research Team Rising Star by Institutional Investor‘s 45th annual ranking of Wall Street’s top equity analysts.

Rising stars are identified as up-and-comers by investors that appreciate great acumen by analysts in designated sectors. The 2016 ranking included responses from 929 voters across 469 firms according to the magazine. “We are very pleased that Karen has been recognized for the strength and substance of her work,” said Karen Blando, Director of Research, at BTIG. “It is a tremendous honor to be commended through Institutional Investor‘s ranking by clients and other industry participants.”

Ms. Koski provides in-depth equity research coverage within the life science and diagnostic tools sector. Prior to her career as a research analyst, she worked as a certified medical laboratory scientist in the blood bank and the clinical microbiology, clinical chemistry, and clinical hematology laboratories at Brigham and Women’s Hospital.

BTIG’s Equity Research Group specializes in the consumer, financials, healthcare, REITs and TMT sectors. Through a diverse team of 30 analysts, BTIG generates research on more than 250 companies under coverage.

For more information about BTIG’s Research capabilities and to access our latest insights, please visit

About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 500 employees, BTIG, LLC and its affiliates operate out of 14 cities in North America, Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs, fixed income (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global sales, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer:

Media Contacts:
Jill Gordon
212.279.3115, ext. 226

[email protected]

Amanda Gold

[email protected]